Johns Hopkins Medicine: Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Study
May 26, 2023
May 26, 2023
BALTIMORE, Maryland, May 26 (TNSjou) -- Johns Hopkins Medicine issued the following news release:
* * *
In mice and human cell models, the drug 32-134D lowered protein levels known to contribute to diabetic macular edema and diabetic retinopathy.
* * *
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study . . .
* * *
In mice and human cell models, the drug 32-134D lowered protein levels known to contribute to diabetic macular edema and diabetic retinopathy.
* * *
Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study . . .